|
JPS5432103A
(en)
|
1977-08-16 |
1979-03-09 |
Nissan Motor Co Ltd |
Preparing apparatus for composite molten metal containing solid particles in dispersed state
|
|
JPS5870649A
(ja)
|
1981-10-22 |
1983-04-27 |
Toyota Motor Corp |
ダイバ−シテイ受信システム
|
|
JPS6122018A
(ja)
|
1984-07-06 |
1986-01-30 |
Green Cross Corp:The |
癌免疫療法増強剤
|
|
JPH0747045B2
(ja)
|
1986-10-15 |
1995-05-24 |
株式会社大協精工 |
積層した注射器用滑栓
|
|
US5670373A
(en)
|
1988-01-22 |
1997-09-23 |
Kishimoto; Tadamitsu |
Antibody to human interleukin-6 receptor
|
|
US5171840A
(en)
|
1988-01-22 |
1992-12-15 |
Tadamitsu Kishimoto |
Receptor protein for human B cell stimulatory factor-2
|
|
US5216128A
(en)
|
1989-06-01 |
1993-06-01 |
Yeda Research And Development Co., Ltd. |
IFN-β2/IL-6 receptor its preparation and pharmaceutical compositions containing it
|
|
JP2998976B2
(ja)
|
1989-07-20 |
2000-01-17 |
忠三 岸本 |
ヒトインタ―ロイキン―６レセプターに対する抗体
|
|
US5605690A
(en)
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5016784A
(en)
|
1990-02-15 |
1991-05-21 |
Dexus Research Inc. |
Applicator for highly reactive materials
|
|
EP1097945B1
(en)
|
1991-03-18 |
2007-07-04 |
New York University |
Monoclonal and chimeric antibody specific for human tumor necrosis factor
|
|
EP0628639B1
(en)
|
1991-04-25 |
1999-06-23 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human interleukin 6 receptor
|
|
US5215534A
(en)
|
1991-12-02 |
1993-06-01 |
Lawrence De Harde |
Safety syringe system
|
|
JP3100727B2
(ja)
|
1992-01-23 |
2000-10-23 |
株式会社大協精工 |
変性ポリシロキサン組成物及び該組成物を被覆した衛生ゴム製品
|
|
FR2694767B1
(fr)
|
1992-08-13 |
1994-10-21 |
Innotherapie Lab Sa |
Anticorps monoclonaux anti-IL6R, et leurs applications.
|
|
KR100232688B1
(ko)
|
1992-09-15 |
1999-12-01 |
스코트 쥐. 홀퀴스트 |
종양 괴사 인자 길항제를 함유하는 tnf-의존성 염증 치료용 제약 조성물
|
|
CA2147466A1
(en)
|
1992-10-20 |
1994-04-28 |
Just P. J. Brakenhoff |
Interleukin-6 receptor antagonists
|
|
US5888511A
(en)
|
1993-02-26 |
1999-03-30 |
Advanced Biotherapy Concepts, Inc. |
Treatment of autoimmune diseases, including AIDS
|
|
US5888510A
(en)
|
1993-07-21 |
1999-03-30 |
Chugai Seiyaku Kabushiki Kaisha |
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
|
|
AU7967294A
(en)
|
1993-10-06 |
1995-05-01 |
Board Of Regents, The University Of Texas System |
A monoclonal anti-human il-6 receptor antibody
|
|
PT783893E
(pt)
|
1994-10-07 |
2012-05-24 |
Chugai Pharmaceutical Co Ltd |
Inibição do crescimento anormal das células sinoviais usando antagonistas de il-6 como componente ativo
|
|
CN1306963C
(zh)
|
1994-10-21 |
2007-03-28 |
岸本忠三 |
用于治疗il－6产生所致疾病的药物组合物
|
|
EP0800829B2
(en)
|
1994-12-29 |
2012-07-25 |
Chugai Seiyaku Kabushiki Kaisha |
Use of a pm-1 antibody or of a mh 166 antibody for enhancing the anti-tumor effect of cisplatin or carboplatin
|
|
ES2264135T3
(es)
|
1995-02-13 |
2006-12-16 |
Chugai Seiyaku Kabushiki Kaisha |
Inhibidor de la descomposicion de proteinas musculares que contienen anticuerpos frente al receptor de il-6.
|
|
JP3172057B2
(ja)
|
1995-04-05 |
2001-06-04 |
株式会社大協精工 |
ラミネートゴム栓
|
|
ZA971600B
(en)
|
1996-02-26 |
1997-09-22 |
Merck & Co Inc |
Treatment of macular edema.
|
|
DK0923941T3
(da)
|
1996-06-27 |
2006-09-18 |
Chugai Pharmaceutical Co Ltd |
Midler mod myelom der skal anvendes sammen med nitrogensennepantitumormidler
|
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
|
AU747883B2
(en)
|
1997-08-15 |
2002-05-30 |
Chugai Seiyaku Kabushiki Kaisha |
Preventives and/or remedies for systemic lupus erythematosus containing anti-IL-6 receptor antibody as the active ingredient
|
|
US20020187150A1
(en)
|
1997-08-15 |
2002-12-12 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient
|
|
DK1074268T3
(da)
|
1998-03-17 |
2008-04-28 |
Chugai Pharmaceutical Co Ltd |
IL-6-receptorantagonistantistofholdige forebyggende eller terapeutiske midler mod inflammatoriske tarmsygdomme
|
|
ATE350060T1
(de)
|
1998-08-24 |
2007-01-15 |
Chugai Pharmaceutical Co Ltd |
Mittel zur vorbeugung oder behandlung von pankreatitis die anti-il-6 receptor antikörper als aktive komponente enthalten
|
|
JP3512349B2
(ja)
|
1999-01-29 |
2004-03-29 |
株式会社大協精工 |
柱状ゴム要素の成形型
|
|
US6670373B1
(en)
|
1999-10-07 |
2003-12-30 |
Eli Lilly And Company |
Compounds and method for inhibiting MRP1
|
|
US6659982B2
(en)
|
2000-05-08 |
2003-12-09 |
Sterling Medivations, Inc. |
Micro infusion drug delivery device
|
|
US6629949B1
(en)
|
2000-05-08 |
2003-10-07 |
Sterling Medivations, Inc. |
Micro infusion drug delivery device
|
|
US8632778B2
(en)
|
2000-08-11 |
2014-01-21 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilized anti-interleukin-6 antibody-containing preparations
|
|
US7148197B2
(en)
|
2000-08-24 |
2006-12-12 |
The Regents Of The University Of California |
Orally administered small peptides synergize statin activity
|
|
EP1327681A4
(en)
|
2000-10-20 |
2004-09-01 |
Chugai Pharmaceutical Co Ltd |
Degraded agonist antibodies
|
|
DE60133029T2
(de)
|
2000-10-25 |
2009-03-12 |
Chugai Seiyaku K.K. |
Mittel zur prävention oder behandlung von psoriasis mit einem il-6-antagonist als wirkstoff
|
|
WO2002036165A1
(fr)
|
2000-10-27 |
2002-05-10 |
Chugai Seiyaku Kabushiki Kaisha |
Agent à base d'antagoniste d'il-6, faisant baisser le niveau des mmp-3 dans le sang
|
|
JP2002209975A
(ja)
|
2001-01-19 |
2002-07-30 |
Daikyo Seiko Ltd |
医薬バイアル用ラミネートゴム栓
|
|
UA80091C2
(en)
|
2001-04-02 |
2007-08-27 |
Chugai Pharmaceutical Co Ltd |
Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
|
|
CA2817619A1
(en)
|
2001-06-08 |
2002-12-08 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
CA2454587C
(en)
|
2001-07-25 |
2012-11-13 |
Protein Design Labs, Inc. |
Stable lyophilized pharmaceutical formulation of igg antibodies
|
|
BRPI0214168B8
(pt)
|
2001-11-14 |
2021-05-25 |
Centocor Inc |
anticorpos anti-il-6, moléculas de ácido nucleico codificando os mesmos, vetores compreendendo as referidas moléculas, composições e formulações compreendendo os referidos anticorpos, bem como métodos de produção dos mesmos
|
|
AU2003211990A1
(en)
|
2002-02-14 |
2003-09-04 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody-containing solution pharmaceuticals
|
|
US20060275294A1
(en)
|
2002-08-22 |
2006-12-07 |
Omoigui Osemwota S |
Method of prevention and treatment of aging, age-related disorders and/or age-related manifestations including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimers disease and cancer
|
|
US20060078533A1
(en)
|
2004-10-12 |
2006-04-13 |
Omoigui Osemwota S |
Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer
|
|
US20060078531A1
(en)
|
2004-10-12 |
2006-04-13 |
Osemwota Sota |
Method of prevention and treatment of atherosclerosis, peripheral vascular disease, coronary artery disease, and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease
|
|
US20060078532A1
(en)
|
2004-10-12 |
2006-04-13 |
Omoigui Osemwota S |
Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease
|
|
US7534427B2
(en)
|
2002-12-31 |
2009-05-19 |
Immunomedics, Inc. |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
|
|
CN1798575A
(zh)
|
2003-04-04 |
2006-07-05 |
健泰科生物技术公司 |
高浓度抗体和蛋白制剂
|
|
EP2062916A3
(en)
|
2003-04-09 |
2009-08-19 |
Genentech, Inc. |
Therapy of autoimmune disease in a patient with an inadequate response to a TNF-Alpha inhibitor
|
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
|
EP1673396A1
(en)
|
2003-09-22 |
2006-06-28 |
BioVation GmbH & Co.KG. |
Use of antibodies for reducing the biological effectiveness of il-6
|
|
DE10355251A1
(de)
|
2003-11-26 |
2005-06-23 |
Merck Patent Gmbh |
Pharmazeutische Zubereitung enthaltend einen Antikörper gegen den EGF-Rezeptor
|
|
US8617550B2
(en)
|
2003-12-19 |
2013-12-31 |
Chugai Seiyaku Kabushiki Kaisha |
Treatment of vasculitis with IL-6 antagonist
|
|
BRPI0506679A
(pt)
|
2004-02-11 |
2007-05-15 |
Warner Lambert Co |
métodos de tratar osteoartrite com antagonistas de il-6
|
|
CN1989439B
(zh)
|
2004-05-06 |
2010-12-29 |
美国政府健康及人类服务部 |
治疗葡萄膜炎的方法以及组合物
|
|
EA014226B1
(ru)
|
2004-07-26 |
2010-10-29 |
Байоджен Айдек Ма Инк. |
Антитела к cd154, их фрагменты и способы применения антител и фрагментов
|
|
US20070036788A1
(en)
|
2004-09-22 |
2007-02-15 |
Ahmed Sheriff |
Use of a compound for reducing the biological effectiveness of il-6
|
|
WO2006046661A1
(ja)
|
2004-10-28 |
2006-05-04 |
Osaka University |
インターロイキン－６阻害剤
|
|
EP1828250A2
(en)
|
2004-12-16 |
2007-09-05 |
Genentech, Inc. |
Methods for treating autoimmune disorders
|
|
CN102961746B
(zh)
|
2005-05-16 |
2016-06-15 |
艾伯维生物技术有限公司 |
TNFα抑制剂治疗腐蚀性多关节炎的用途
|
|
JPWO2007013168A1
(ja)
|
2005-07-29 |
2009-02-05 |
富士通株式会社 |
Ｒｆタグ及びｒｆタグを製造する方法
|
|
CN101312744A
(zh)
|
2005-11-22 |
2008-11-26 |
惠氏公司 |
免疫球蛋白融合蛋白制剂
|
|
CN101326195B9
(zh)
|
2005-12-13 |
2022-11-11 |
伊莱利利公司 |
抗il-17抗体
|
|
US20070143168A1
(en)
|
2005-12-19 |
2007-06-21 |
Lucent Technologies Inc. |
Meeting scheduling service
|
|
US20080131374A1
(en)
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
|
US8080248B2
(en)
|
2006-06-02 |
2011-12-20 |
Regeneron Pharmaceuticals, Inc. |
Method of treating rheumatoid arthritis with an IL-6R antibody
|
|
ES2398076T3
(es)
|
2006-06-02 |
2013-03-13 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos de alta afinidad contra el receptor de IL-6 humano
|
|
BRPI0713421A2
(pt)
|
2006-06-14 |
2012-03-13 |
Imclone Systems Incorporated |
Formulação liofolizada, formulação aquosa adequada para a liofilização, e, métodos para estabilizar am anticorpo e para tratar um mamífero
|
|
EP2057191A1
(en)
|
2006-08-18 |
2009-05-13 |
Ablynx N.V. |
Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling
|
|
US20100129354A1
(en)
|
2006-10-27 |
2010-05-27 |
Ablynx N.V. |
Intranasal delivery of polypeptides and proteins
|
|
AU2008255352B2
(en)
|
2007-05-31 |
2014-05-22 |
Genmab A/S |
Stable IgG4 antibodies
|
|
EP2206775B1
(en)
|
2007-09-26 |
2016-06-29 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-il-6 receptor antibody
|
|
WO2009095489A2
(en)
|
2008-02-01 |
2009-08-06 |
Ablynx N.V. |
Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
|
|
WO2009109584A1
(en)
|
2008-03-07 |
2009-09-11 |
Ferring International Center S. A. |
ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX
|
|
KR102057826B1
(ko)
|
2008-04-11 |
2019-12-20 |
추가이 세이야쿠 가부시키가이샤 |
복수 분자의 항원에 반복 결합하는 항원 결합 분자
|
|
WO2009140348A2
(en)
|
2008-05-13 |
2009-11-19 |
Novimmune Sa |
Anti-il-6/il-6r antibodies and methods of use thereof
|
|
TWI440469B
(zh)
|
2008-09-26 |
2014-06-11 |
Chugai Pharmaceutical Co Ltd |
Improved antibody molecules
|
|
JP4885308B2
(ja)
|
2009-03-19 |
2012-02-29 |
中外製薬株式会社 |
改良された抗体分子を含有する製剤
|
|
JO3030B1
(ar)
|
2009-06-26 |
2016-09-05 |
Galapagos Nv |
مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات
|
|
JP5607736B2
(ja)
|
2009-07-07 |
2014-10-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃ型肝炎ウイルスプロテアーゼ阻害剤のための医薬組成物
|
|
JO3417B1
(ar)
|
2010-01-08 |
2019-10-20 |
Regeneron Pharma |
الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r
|
|
KR20130065662A
(ko)
|
2010-05-07 |
2013-06-19 |
조마 테크놀로지 리미티드 |
ⅠＬ-1β 관련 병태의 치료 방법
|
|
US9427531B2
(en)
|
2010-06-28 |
2016-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Auto-injector
|
|
US9261526B2
(en)
|
2010-08-26 |
2016-02-16 |
Blast Motion Inc. |
Fitting system for sporting equipment
|
|
TWI603738B
(zh)
|
2010-11-08 |
2017-11-01 |
建南德克公司 |
皮下投予抗－ｉｌ－６受體抗體
|
|
US8440890B1
(en)
|
2011-03-09 |
2013-05-14 |
Pioneer Hi Bred International Inc |
Maize variety inbred PH1D0D
|
|
CA2746171C
(en)
|
2011-07-13 |
2018-11-06 |
William Jani |
Retrievable stimulation frac (rsf) plug
|
|
TWI589299B
(zh)
|
2011-10-11 |
2017-07-01 |
再生元醫藥公司 |
用於治療類風濕性關節炎之組成物及其使用方法
|
|
US9943594B2
(en)
*
|
2011-10-11 |
2018-04-17 |
Sanofi Biotechnology |
Methods for the treatment of rheumatoid arthritis
|
|
CN103947096B
(zh)
|
2011-10-21 |
2016-09-21 |
Abb研究有限公司 |
用于检测ac/dc转换器中失效整流器的方法和系统
|
|
US9248242B2
(en)
|
2012-04-20 |
2016-02-02 |
Safety Syringes, Inc. |
Anti-needle stick safety device for injection device
|
|
BR112015010360A8
(pt)
|
2012-11-08 |
2018-01-16 |
Eleven Biotherapeutics Inc |
antagonistas de il-6 e utilização dos mesmos.
|
|
US20140155827A1
(en)
|
2012-12-03 |
2014-06-05 |
Mylan, Inc. |
Medicament information system and method
|
|
US20150050277A1
(en)
|
2013-03-15 |
2015-02-19 |
Aerpio Therapeutics Inc. |
Compositions and methods for treating ocular diseases
|
|
SG11201601625UA
(en)
|
2013-09-11 |
2016-04-28 |
Glenn Abrahmsohn |
Hypertonic antimicrobial therapeutic compositions
|
|
JP6343011B2
(ja)
|
2013-10-07 |
2018-06-13 |
プレステージ バイオファーマ プライベート リミテッド |
抗体発現用バイシストロニック発現ベクター及びそれを用いた抗体の生産方法
|
|
ES2799439T3
(es)
|
2013-11-22 |
2020-12-17 |
Sanofi Biotechnology |
Composiciones para el tratamiento de la artritis reumatoide y métodos de uso de las mismas
|
|
AU2014352801B2
(en)
|
2013-11-22 |
2020-05-28 |
Regeneron Pharmaceuticals, Inc. |
Compositions for the treatment of rheumatoid arthritis and methods of using same
|
|
IL295414B2
(en)
|
2014-03-27 |
2026-02-01 |
Takeda Pharmaceuticals Co |
Compositions and methods for treating macular edema due to diabetes
|
|
EP3152235B1
(en)
|
2014-05-29 |
2021-08-25 |
MacroGenics, Inc. |
Tri-specific binding molecules and methods of use thereof
|
|
AU2015317905A1
(en)
|
2014-09-16 |
2017-03-16 |
Regeneron Pharmaceuticals, Inc. |
Compositions for improving the health related quality of life of rheumatoid arthritis patients
|
|
TW201723174A
(zh)
|
2015-09-03 |
2017-07-01 |
持田製藥股份有限公司 |
重組蛋白質的製造方法
|
|
IL319993A
(en)
|
2015-11-03 |
2025-06-01 |
Sanofi Biotechnology |
Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same
|
|
WO2017106312A1
(en)
|
2015-12-18 |
2017-06-22 |
Drexel University |
Methods of modulating levels of il-6 and pd-l1
|
|
BR112018067851A2
(pt)
|
2016-03-07 |
2019-02-05 |
Regeneron Pharma |
composições e métodos para o tratamento de artrite reumatoide
|
|
ES2642723B1
(es)
|
2016-05-12 |
2018-10-22 |
Servizo Galego De Saúde (Sergas) |
Uso de los niveles de anticuerpos anti-CD26 como biomarcadores de enfermedades autoinmunes y/o inflamatorias.
|
|
WO2018007442A1
(en)
|
2016-07-06 |
2018-01-11 |
Ablynx N.V. |
Treatment of il-6r related diseases
|
|
AU2019329958B2
(en)
|
2018-08-29 |
2025-05-29 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for treating subjects having rheumatoid arthritis
|
|
CH715771A2
(de)
|
2019-01-23 |
2020-07-31 |
Pedretti Mauro |
Verfahren und Vorrichtung zum Speichern von Energie.
|
|
BR112021014377A2
(pt)
|
2019-01-31 |
2021-12-28 |
Regeneron Pharma |
Composições e métodos para o tratamento de artrite idiopática juvenil
|
|
AU2020261431A1
(en)
|
2019-04-24 |
2021-12-09 |
Regeneron Pharmaceuticals, Inc. |
Methods of diagnosis and treatment of rheumatoid arthritis
|
|
EP3980459A1
(en)
|
2019-06-04 |
2022-04-13 |
Sanofi Biotechnology |
Compositions and methods for treating pain in subj ects with rheumatoid arthritis
|
|
BR112021025060A2
(pt)
|
2019-06-12 |
2022-02-22 |
Regeneron Pharma |
Dosagem modificada de tocilizumab subcutâneo para artrite reumatóide
|
|
US12135885B2
(en)
|
2020-01-31 |
2024-11-05 |
Hewlett Packard Enterprise Development Lp |
Virtual storage policies for virtual persistent volumes
|
|
IL298088A
(en)
|
2020-05-26 |
2023-01-01 |
Sanofi Biotechnology |
The compositions containing an antibody against the interleukin-6 receptor for the treatment of rheumatoid arthritis and methods of using them
|
|
JP7841752B2
(ja)
|
2020-05-29 |
2026-04-07 |
サノフィ・バイオテクノロジー |
関節リウマチを有する対象における非炎症性疼痛を治療するための組成物および方法
|